The global Venous Thromboembolism Therapy market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
A venous thrombus is a blood clot (thrombus) that forms within a vein. Thrombosis is a term for a blood clot occurring inside a blood vessel. A common type of venous thrombosis is a deep vein thrombosis (DVT), which is a blood clot in the deep veins of the leg. If the thrombus breaks off (embolizes) and flows towards the lungs, it can become a pulmonary embolism (PE), a blood clot in the lungs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Venous Thromboembolism Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Venous Thromboembolism Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Venous Thromboembolism Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Venous Thromboembolism Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Venous Thromboembolism Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Venous Thromboembolism Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Venous Thromboembolism Therapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Stryker, AngioDynamics, Cook Medical, Cardinal Health, DJO Global, Philips Holding, ArjoHuntleigh AB, Argon Medical Devices, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Venous Thromboembolism Therapy market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
麻豆原创 segment by Application
Hospitals
Clinics
Others
Major players covered
Medtronic
Boston Scientific
Stryker
AngioDynamics
Cook Medical
Cardinal Health
DJO Global
Philips Holding
ArjoHuntleigh AB
Argon Medical Devices
DaeSung Maref
ALN Implants Chirurgicaux
Lifetech Scientific
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Venous Thromboembolism Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Venous Thromboembolism Therapy, with price, sales quantity, revenue, and global market share of Venous Thromboembolism Therapy from 2020 to 2025.
Chapter 3, the Venous Thromboembolism Therapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Venous Thromboembolism Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Venous Thromboembolism Therapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Venous Thromboembolism Therapy.
Chapter 14 and 15, to describe Venous Thromboembolism Therapy sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Venous Thromboembolism Therapy Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Non-Segmented Pneumatic Compression Pumps
1.3.3 Segmented Pneumatic Compression Pumps without Gradient
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Venous Thromboembolism Therapy Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Venous Thromboembolism Therapy 麻豆原创 Size & Forecast
1.5.1 Global Venous Thromboembolism Therapy Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Venous Thromboembolism Therapy Sales Quantity (2020-2031)
1.5.3 Global Venous Thromboembolism Therapy Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Venous Thromboembolism Therapy Product and Services
2.1.4 Medtronic Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Venous Thromboembolism Therapy Product and Services
2.2.4 Boston Scientific Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 Stryker
2.3.1 Stryker Details
2.3.2 Stryker Major Business
2.3.3 Stryker Venous Thromboembolism Therapy Product and Services
2.3.4 Stryker Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Stryker Recent Developments/Updates
2.4 AngioDynamics
2.4.1 AngioDynamics Details
2.4.2 AngioDynamics Major Business
2.4.3 AngioDynamics Venous Thromboembolism Therapy Product and Services
2.4.4 AngioDynamics Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 AngioDynamics Recent Developments/Updates
2.5 Cook Medical
2.5.1 Cook Medical Details
2.5.2 Cook Medical Major Business
2.5.3 Cook Medical Venous Thromboembolism Therapy Product and Services
2.5.4 Cook Medical Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Cook Medical Recent Developments/Updates
2.6 Cardinal Health
2.6.1 Cardinal Health Details
2.6.2 Cardinal Health Major Business
2.6.3 Cardinal Health Venous Thromboembolism Therapy Product and Services
2.6.4 Cardinal Health Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Cardinal Health Recent Developments/Updates
2.7 DJO Global
2.7.1 DJO Global Details
2.7.2 DJO Global Major Business
2.7.3 DJO Global Venous Thromboembolism Therapy Product and Services
2.7.4 DJO Global Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 DJO Global Recent Developments/Updates
2.8 Philips Holding
2.8.1 Philips Holding Details
2.8.2 Philips Holding Major Business
2.8.3 Philips Holding Venous Thromboembolism Therapy Product and Services
2.8.4 Philips Holding Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Philips Holding Recent Developments/Updates
2.9 ArjoHuntleigh AB
2.9.1 ArjoHuntleigh AB Details
2.9.2 ArjoHuntleigh AB Major Business
2.9.3 ArjoHuntleigh AB Venous Thromboembolism Therapy Product and Services
2.9.4 ArjoHuntleigh AB Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 ArjoHuntleigh AB Recent Developments/Updates
2.10 Argon Medical Devices
2.10.1 Argon Medical Devices Details
2.10.2 Argon Medical Devices Major Business
2.10.3 Argon Medical Devices Venous Thromboembolism Therapy Product and Services
2.10.4 Argon Medical Devices Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Argon Medical Devices Recent Developments/Updates
2.11 DaeSung Maref
2.11.1 DaeSung Maref Details
2.11.2 DaeSung Maref Major Business
2.11.3 DaeSung Maref Venous Thromboembolism Therapy Product and Services
2.11.4 DaeSung Maref Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 DaeSung Maref Recent Developments/Updates
2.12 ALN Implants Chirurgicaux
2.12.1 ALN Implants Chirurgicaux Details
2.12.2 ALN Implants Chirurgicaux Major Business
2.12.3 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product and Services
2.12.4 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 ALN Implants Chirurgicaux Recent Developments/Updates
2.13 Lifetech Scientific
2.13.1 Lifetech Scientific Details
2.13.2 Lifetech Scientific Major Business
2.13.3 Lifetech Scientific Venous Thromboembolism Therapy Product and Services
2.13.4 Lifetech Scientific Venous Thromboembolism Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Lifetech Scientific Recent Developments/Updates
3 Competitive Environment: Venous Thromboembolism Therapy by Manufacturer
3.1 Global Venous Thromboembolism Therapy Sales Quantity by Manufacturer (2020-2025)
3.2 Global Venous Thromboembolism Therapy Revenue by Manufacturer (2020-2025)
3.3 Global Venous Thromboembolism Therapy Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Venous Thromboembolism Therapy by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Venous Thromboembolism Therapy Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Venous Thromboembolism Therapy Manufacturer 麻豆原创 Share in 2024
3.5 Venous Thromboembolism Therapy 麻豆原创: Overall Company Footprint Analysis
3.5.1 Venous Thromboembolism Therapy 麻豆原创: Region Footprint
3.5.2 Venous Thromboembolism Therapy 麻豆原创: Company Product Type Footprint
3.5.3 Venous Thromboembolism Therapy 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Venous Thromboembolism Therapy 麻豆原创 Size by Region
4.1.1 Global Venous Thromboembolism Therapy Sales Quantity by Region (2020-2031)
4.1.2 Global Venous Thromboembolism Therapy Consumption Value by Region (2020-2031)
4.1.3 Global Venous Thromboembolism Therapy Average Price by Region (2020-2031)
4.2 North America Venous Thromboembolism Therapy Consumption Value (2020-2031)
4.3 Europe Venous Thromboembolism Therapy Consumption Value (2020-2031)
4.4 Asia-Pacific Venous Thromboembolism Therapy Consumption Value (2020-2031)
4.5 South America Venous Thromboembolism Therapy Consumption Value (2020-2031)
4.6 Middle East & Africa Venous Thromboembolism Therapy Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
5.2 Global Venous Thromboembolism Therapy Consumption Value by Type (2020-2031)
5.3 Global Venous Thromboembolism Therapy Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
6.2 Global Venous Thromboembolism Therapy Consumption Value by Application (2020-2031)
6.3 Global Venous Thromboembolism Therapy Average Price by Application (2020-2031)
7 North America
7.1 North America Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
7.2 North America Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
7.3 North America Venous Thromboembolism Therapy 麻豆原创 Size by Country
7.3.1 North America Venous Thromboembolism Therapy Sales Quantity by Country (2020-2031)
7.3.2 North America Venous Thromboembolism Therapy Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
8.2 Europe Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
8.3 Europe Venous Thromboembolism Therapy 麻豆原创 Size by Country
8.3.1 Europe Venous Thromboembolism Therapy Sales Quantity by Country (2020-2031)
8.3.2 Europe Venous Thromboembolism Therapy Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Venous Thromboembolism Therapy 麻豆原创 Size by Region
9.3.1 Asia-Pacific Venous Thromboembolism Therapy Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Venous Thromboembolism Therapy Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
10.2 South America Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
10.3 South America Venous Thromboembolism Therapy 麻豆原创 Size by Country
10.3.1 South America Venous Thromboembolism Therapy Sales Quantity by Country (2020-2031)
10.3.2 South America Venous Thromboembolism Therapy Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Venous Thromboembolism Therapy Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Venous Thromboembolism Therapy Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Venous Thromboembolism Therapy 麻豆原创 Size by Country
11.3.1 Middle East & Africa Venous Thromboembolism Therapy Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Venous Thromboembolism Therapy Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Venous Thromboembolism Therapy 麻豆原创 Drivers
12.2 Venous Thromboembolism Therapy 麻豆原创 Restraints
12.3 Venous Thromboembolism Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Venous Thromboembolism Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Venous Thromboembolism Therapy
13.3 Venous Thromboembolism Therapy Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Venous Thromboembolism Therapy Typical Distributors
14.3 Venous Thromboembolism Therapy Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Medtronic
Boston Scientific
Stryker
AngioDynamics
Cook Medical
Cardinal Health
DJO Global
Philips Holding
ArjoHuntleigh AB
Argon Medical Devices
DaeSung Maref
ALN Implants Chirurgicaux
Lifetech Scientific
听
听
*If Applicable.